Report NCDs

About NCDs

Given the sheer number of cases and fatalities associated with non-communicable diseases (NCDs), it can be said NCDs are the greatest challenge facing public health and healthcare. HGPI has worked as the Japanese representative of NCD Alliance, NCD Alliance Japan, to reflect the voices of patients and other stakeholders in policy by connecting them to domestic and international multi-stakeholders. To that end, we have advocated for policies across NCD fields and have undertaken initiatives to educate and support patient leaders and representatives. HGPI also stimulates multi-stakeholder discussions and generates policy recommendations to contribute to advancing policies related to specific fields like cancer, cardiovascular diseases (CVDs), diabetes, and renal diseases.

[Event Report] Non-partisan Diet Member study session: “Challenges and Prospects for Improving Patient Access to Genomic Cancer Medicine” (December 12, 2023)
2023-12-18

[Event Report] Non-partisan Diet Member study session: “Challenges and Prospects for Imp ...>>

[Event Report] The 1st Advisory Board Meeting for Patient and Public Involvement (PPI) Support Project “Necessary Steps for Promoting PPI in Policy Making” (October 3, 2023)
2023-11-28

[Event Report] The 1st Advisory Board Meeting for Patient and Public Involvement (PPI) S ...>>

[Event Report] The 120th HGPI Seminar – Necessary Steps for Promoting the Integrated Provision of Palliative Care from Post-diagnosis to End-of-Life With Addressing Cancer Related Pain (October 10, 2023)
2023-11-10

[Event Report] The 120th HGPI Seminar – Necessary Steps for Promoting the Integrated Pro ...>>

[Event Report] The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Policy Dialogue Event “Challenges and Prospects for the Improving Patient Access to Genomic Cancer Medicine” (October 11, 2023)
2023-11-06

[Event Report] The Project for Considering the Future of Precision Medicine with Industr ...>>

[Policy Recommendations] The 6 Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Control (November 1, 2023)
2023-11-01

[Policy Recommendations] The 6 Steps for Engaging and Cooperating with Patients, Citizen ...>>

[Event Report] HGPI and the Japan Pharmaceutical Manufacturers Association’s Aging Group Joint Symposium “Health Challenges that Accompany Population Aging – Dementia and Cancer.” (September 8, 2023)
2023-10-31

[Event Report] HGPI and the Japan Pharmaceutical Manufacturers Association’s Aging Group ...>>

[Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
2023-09-07

[Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Ea ...>>

[Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, 2023)
2023-08-10

[Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, ...>>

[Event Report] HGPI Special Seminar “How can patients and the public participate meaningfully in health policymaking?” (May 23, 2023)
2023-07-28

[Event Report] HGPI Special Seminar “How can patients and the public participate meaning ...>>

[Announcement] Health and Global Policy Institute and Japan Kidney Association Form Comprehensive Agreement on Collaboration and Cooperation for Kidney Disease (June 28, 2023)
2023-07-14

[Announcement] Health and Global Policy Institute and Japan Kidney Association Form Comp ...>>

[Research Report] Results of Internet Survey on Genomic Cancer Medicine (Summary)(May 11, 2023)
2023-06-12

[Research Report] Results of Internet Survey on Genomic Cancer Medicine (Summary)(May 11 ...>>

[Event Report] The Cardiovascular Disease Control Promotion Project “Nationwide Summit for Promoting CVD Control” (April 25, 2023)
2023-05-29

[Event Report] The Cardiovascular Disease Control Promotion Project “Nationwide Summit f ...>>

PageTop